Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0230
+0.0002 (0.88%)
At close: Nov 5, 2026
Bioxytran Employees
Bioxytran had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Bioxytran the 43,367th largest employer in the world and 7,028th in the United States.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
2.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 214 |
| Vaxxinity | 65 |
| BioAtla | 41 |
| Emmaus Life Sciences | 33 |
| Vaccinex | 27 |
| America Great Health | 5 |
| AccuStem Sciences | 4 |
| Abpro Holdings | 3 |
Bioxytran News
- 1 day ago - Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets - GlobeNewsWire
- 17 days ago - Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar - GlobeNewsWire
- 2 months ago - Bioxytran Quarterly report: Q2 2026 - Filings
- 3 months ago - Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs - GlobeNewsWire
- 3 months ago - Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research - GlobeNewsWire
- 5 months ago - Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25 - GlobeNewsWire
- 5 months ago - Bioxytran Quarterly report: Q1 2026 - Filings
- 6 months ago - Bioxytran Annual report: Q4 2025 - Filings